Cargando…
MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
Cancer stem cells are considered as the cell population which is responsible for chemoresistance and treatment failure in breast cancer patients. Therefore, it is urgent to explore the mechanism by which cancer stem cells survive under the treatment of chemotherapeutic drugs such as cisplatin. In th...
Autores principales: | Xie, Qing, Wang, Shuai, Zhao, Yue, Zhang, Zhenchao, Qin, Chuan, Yang, Xianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400641/ https://www.ncbi.nlm.nih.gov/pubmed/28423543 http://dx.doi.org/10.18632/oncotarget.15781 |
Ejemplares similares
-
Inhibition of TRIM32 Induced by miR-519d Increases the Sensitivity of Colorectal Cancer Cells to Cisplatin
por: Su, Xueliang, et al.
Publicado: (2020) -
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
por: Fornari, Francesca, et al.
Publicado: (2015) -
MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression
por: Ma, Haiming, et al.
Publicado: (2020) -
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
por: Pang, Yingxin, et al.
Publicado: (2014) -
miR-519d downregulates LEP expression to inhibit preeclampsia development
por: Cai, Hairui, et al.
Publicado: (2021)